Hassel Stefanie, Almeida Jorge Rc, Kerr Natalie, Nau Sharon, Ladouceur Cecile D, Fissell Kate, Kupfer David J, Phillips Mary L
Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
Bipolar Disord. 2008 Dec;10(8):916-27. doi: 10.1111/j.1399-5618.2008.00641.x.
To examine abnormal patterns of frontal cortical-subcortical activity in response to emotional stimuli in euthymic individuals with bipolar disorder type I in order to identify trait-like, pathophysiologic mechanisms of the disorder. We examined potential confounding effects of total psychotropic medication load and illness variables upon neural abnormalities.
We analyzed neural activity in 19 euthymic bipolar and 24 healthy individuals to mild and intense happy, fearful and neutral faces.
Relative to healthy individuals, bipolar subjects had significantly increased left striatal activity in response to mild happy faces (p < 0.05, corrected), decreased right dorsolateral prefrontal cortical (DLPFC) activity in response to neutral, mild and intense happy faces, and decreased left DLPFC activity in response to neutral, mild and intense fearful faces (p < 0.05, corrected). Bipolar and healthy individuals did not differ in amygdala activity in response to either emotion. In bipolar individuals, there was no significant association between medication load and abnormal activity in these regions, but a negative relationship between age of illness onset and amygdala activity in response to mild fearful faces (p = 0.007). Relative to those without comorbidities, bipolar individuals with comorbidities showed a trend increase in left striatal activity in response to mild happy faces.
Abnormally increased striatal activity in response to potentially rewarding stimuli and decreased DLPFC activity in response to other emotionally salient stimuli may underlie mood instabilities in euthymic bipolar individuals, and are more apparent in those with comorbid diagnoses. No relationship between medication load and abnormal neural activity in bipolar individuals suggests that our findings may reflect pathophysiologic mechanisms of the illness rather than medication confounds. Future studies should examine whether this pattern of abnormal neural activity could distinguish bipolar from unipolar depression.
研究Ⅰ型双相情感障碍缓解期患者在面对情绪刺激时额叶皮质 - 皮质下活动的异常模式,以确定该疾病类似特质的病理生理机制。我们研究了精神药物总负荷和疾病变量对神经异常的潜在混杂影响。
我们分析了19名处于缓解期的双相情感障碍患者和24名健康个体在面对轻度和强烈的开心、恐惧及中性面孔时的神经活动。
与健康个体相比,双相情感障碍患者在面对轻度开心面孔时左侧纹状体活动显著增加(p < 0.05,校正后),在面对中性、轻度和强烈开心面孔时右侧背外侧前额叶皮质(DLPFC)活动减少,在面对中性、轻度和强烈恐惧面孔时左侧DLPFC活动减少(p < 0.05,校正后)。双相情感障碍患者和健康个体在面对任何一种情绪时杏仁核活动均无差异。在双相情感障碍患者中,这些区域的药物负荷与异常活动之间无显著关联,但疾病发病年龄与面对轻度恐惧面孔时的杏仁核活动呈负相关(p = 0.007)。与无共病的患者相比,有共病的双相情感障碍患者在面对轻度开心面孔时左侧纹状体活动有增加趋势。
对潜在奖励性刺激反应时纹状体活动异常增加,以及对其他情绪显著刺激反应时DLPFC活动减少,可能是双相情感障碍缓解期患者情绪不稳定的基础,且在有共病诊断的患者中更明显。双相情感障碍患者的药物负荷与神经活动异常之间无关联,这表明我们的发现可能反映了该疾病的病理生理机制,而非药物混杂因素。未来研究应探讨这种神经活动异常模式是否能区分双相情感障碍和单相抑郁症。